Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), versus ($0.21) reported last year.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• BofA lists top 5 themes driving next $1tn in incremental semi sales